Jefferies Financial Group’s Bio-Techne TECH Stock Holding History

Jefferies Financial Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.83M	Buy	+35,000	New	+$2.1M	0.01%	673

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jefferies Financial Group's TECH Position: Q1 2026 in Review

Jefferies Financial Group sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 55,666 shares — an estimated $3.34M sold.

Jefferies Financial Group first reported a position in TECH in Q3 2017 and held it in 17 quarters. The position peaked at $3.76M in Q4 2024. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

Jefferies Financial Group reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
Jefferies Financial Group sold 55,666 Bio-Techne shares in Q1 2026, an estimated $3.34M.
Jefferies Financial Group first reported a position in Bio-Techne in Q3 2017 and held it in 17 quarters.
Jefferies Financial Group's Bio-Techne position peaked at $3.76M in Q4 2024.
582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.